Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kodiak Sciences Inc - Common Stock (NQ:KOD)

12.19 +0.59 (+5.09%)
Streaming Delayed Price Updated: 3:15 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kodiak Sciences Inc - Common Stock

< Previous 1 2 3 4 5 Next >
Bonds Are Screaming “Recession.” That’s Great News For One Top Sector.
The 10-2 year treasury yield spread is close to zero. Here's what you should do about this warning sign of a coming recession. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
Via Benzinga
Recap: Kodiak Sciences Q4 Earnings
Kodiak Sciences (NASDAQ:KOD) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Kodiak... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The... 
Via Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label... 
Via Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Read Why Barclays Analyst Is 'Negatively Biased' On Kodiak Sciences
Barclays has lowered the firm's price target on Kodiak Sciences Inc (NASDAQ: KOD 
Via Benzinga
What 4 Analyst Ratings Have To Say About Kodiak Sciences
Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings: 
Via Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the... 
Via Talk Markets
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature. 
Via InvestorPlace
Expert Ratings For Kodiak Sciences
Analysts have provided the following ratings for Kodiak Sciences (NASDAQ:KOD) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading. 
Via Benzinga
63 Biggest Movers From Yesterday
Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a... 
Via Benzinga
KOD Stock Alert: Why Is Kodiak Sciences Plunging 80% Today?
Disappointing drug trial results have sent Kodiak Sciences and shares of KOD stock plunging more than 80% in today's trading session. 
Via InvestorPlace
Mid-Afternoon Market Update: U.S. Stocks Extend Losses; Dow Dips 300 Points
U.S. stocks extended losses toward the end of trading, with the Dow Jones falling 300 points on Wednesday. US President Biden late Tuesday announced sanctions on some Russian... 
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Negative; Nasdaq Drops 50 Points
U.S. stocks turned lower midway through trading after recording sharp losses on Tuesday. US President Biden late Tuesday announced sanctions on some Russian banks and individuals... 
Via Benzinga
S&P 500 Slips Further into Correction Territory as Stocks Give Up Gains
Stocks have pulled back from this morning's gains, amid the ongoing Russia-Ukraine border crisis, with all three benchmarks looking to extend their losing streaks. 
Via Talk Markets
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share... 
Via Benzinga
Kodiak Stock Pummeled After Attempt To Improve On Regeneron's Blockbuster Backfired
Kodiak hoped a less frequent dosing plan would benefit patients with an eye disease. 
Via Investor's Business Daily
Mid-Morning Market Update: U.S. Stocks Open Higher; Lowe's Tops Q4 Expectations
U.S. stocks opened higher this morning after recording sharp losses on Tuesday. US President Biden late Tuesday announced sanctions on some Russian banks and individuals.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
Why Kodiak Sciences Shares Are Plunging Today
Kodiak Sciences Inc (NASDAQ: KOD) has announced topline results from its Phase 2b/3 trial evaluating KSI-301 in treatment-naïve subjects with neovascular (wet) age-... 
Via Benzinga
Executives Buy Around $500M Of 4 Stocks
US stocks traded lower on Friday after recording sharp losses on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher; Alphabet Tops Q4 Views
Pre-open movers 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.